Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (423)

« Back to Publications

ssessment and management of dengue.

Adhikari S. et al, (2025), BMJ (Clinical research ed.), 388

Mismanagement of Patients with High Altitude Illness Evacuated from the Mount Everest Region in Nepal.

Pant SR. et al, (2024), High altitude medicine & biology, 25, 348 - 349

Higher oxygen content and transport characterize high-altitude ethnic Tibetan women with the highest lifetime reproductive success.

Ye S. et al, (2024), Proceedings of the National Academy of Sciences of the United States of America, 121

Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial

Schilling WHK. et al, (2024), PLOS Medicine, 21, e1004428 - e1004428

Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

Horby PW. et al, (2024)

Pathogen diversity and antimicrobial resistance transmission of Salmonella enterica serovars Typhi and Paratyphi A in Bangladesh, Nepal, and Malawi: a genomic epidemiological study.

Dyson ZA. et al, (2024), The Lancet. Microbe, 5

etrospective investigation of the population structure and geospatial distribution of Salmonella Paratyphi A in Kathmandu, Nepal.

Mylona E. et al, (2024), PLoS neglected tropical diseases, 18

Molnupiravir or nirmatrelvir-ritonavir versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Horby PW. et al, (2024)

Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

Naghavi M. et al, (2024), The Lancet, 403, 2100 - 2132

Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021

Schumacher AE. et al, (2024), The Lancet, 403, 1989 - 2056

The facilitators of and barriers to antimicrobial use and misuse in Lalitpur, Nepal: a qualitative study.

Udas S. et al, (2024), BMC public health, 24

High-dose corticosteroid therapy in COVID-19: the RECOVERY trial – Authors' reply

Peto L. et al, (2024), The Lancet, 403, 1339 - 1340

Immune responses to typhoid conjugate vaccine in a two dose schedule among Nepalese children <2 years of age

Bijukchhe SM. et al, (2024), Vaccine, 42, 2018 - 2025

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

Faust SN. et al, (2024), The Lancet Child & Adolescent Health, 8, 190 - 200

Estimating the subnational prevalence of antimicrobial resistant Salmonella enterica serovars Typhi and Paratyphi A infections in 75 endemic countries, 1990–2019: a modelling study

Browne AJ. et al, (2024), The Lancet Global Health, 12, e406 - e418

Load More

1
2
3
4
5
6
7
...
»